Zellner Christian, Pullinger Clive R, Aouizerat Bradley E, Frost Philip H, Kwok Pui-Yan, Malloy Mary J, Kane John P
Cardiovascular Research Institute, University of California, San Francisco 94143-0130, USA.
Hum Mutat. 2005 Jan;25(1):18-21. doi: 10.1002/humu.20121.
HM74 (GPR109B) and the highly homologous gene, HM74A (GPR109A) code for Gi-G protein-coupled orphan receptors that recently have been discovered to be involved in the metabolic effects of niacin. The B vitamin niacin is an important agent used in the treatment of dyslipidemias, but its use is limited by side effects. The novel role of the adjacent HM74 and HM74A genes in the metabolism of niacin may provide new targets for drug development. Human genetic variations in HM74 and HM74A have been reported but have not been studied in detail. These variations may play a role in the response to agents targeting receptors coded by these genes. Here we show that many of the nonsynonymous SNPs listed in public databases for HM74 and HM74A are artifacts resulting from extensive homology between these two genes. This may be representative of a neglected phenomenon in reporting sequences of highly homologous genes. We provide primer sequences that permit selective amplification of the complete coding regions of HM74 and HM74A. Using these primers, we show that subsequent sequencing of HM74 and HM74A reveals a novel and unique variation in the HM74A gene. Haplotype analysis suggests four SNPs can define the five major haplotypes that lie within a single haplotype block encompassing these two genes.
HM74(GPR109B)和高度同源的基因HM74A(GPR109A)编码Gi-G蛋白偶联的孤儿受体,最近发现这些受体参与烟酸的代谢效应。B族维生素烟酸是用于治疗血脂异常的重要药物,但其应用受到副作用的限制。相邻的HM74和HM74A基因在烟酸代谢中的新作用可能为药物开发提供新的靶点。已报道了HM74和HM74A中的人类基因变异,但尚未进行详细研究。这些变异可能在针对由这些基因编码的受体的药物反应中起作用。在这里,我们表明公共数据库中列出的HM74和HM74A的许多非同义单核苷酸多态性(SNP)是由于这两个基因之间的广泛同源性导致的假象。这可能代表了在报告高度同源基因序列时被忽视的一种现象。我们提供了允许选择性扩增HM74和HM74A完整编码区的引物序列。使用这些引物,我们表明随后对HM74和HM74A的测序揭示了HM74A基因中的一种新的独特变异。单倍型分析表明,四个SNP可以定义位于包含这两个基因的单个单倍型块内的五个主要单倍型。